Renata approves 60pc cash, 25pc stock dividend
Sunday, 30 May 2010
Renata Limited has approved 60 per cent cash dividend and 25 per cent stock dividend (bonus share 4:1) for the year 2009. The dividend was approved at its 37th annual general meeting (AGM) held Saturday.
Renata Chairman SH Kabir presided over the meeting, said a press release.
CEO and Managing Director Kaiser Kabir, directors Dr Sarwar Ali, Sajida Humayun Kabir, A Hasanat Khan, Manzoor Hasan, Company Secretary Md Shafiul Alam, senior executives of the company and a large number of shareholders attended the AGM.
In the year 2009, Renata's combined turnover and net profit grew by 26.2 per cent and 39.3 per cent respectively last year. The earning per share (EPS) stood at Tk 417.38 compared to Tk 299.55 in the year 2008. The retained earnings of the company on December 31st 2009 amounted to a healthy Tk 1.7 billion. Renata also contributed Tk 862 million to the national exchequer in the form of corporate taxes, value added tax and import duties.
The Chairman informed the meeting that in last six years, Renata increased the number of manufacturing facilities from one to five-fold. The entire investments were financed through internally generated funds, and the company remains free of long-term debt.
Renata's pharmaceutical business registered a growth of 27.5 per cent and improved its market rank from 6th to 5th. In the animal health business, Renata retained its number 1 position for the 13th consecutive year with a sales growth of 28 per cent.
In contract manufacturing, Renata produced Sprinkles for SMC and UNICEF, and Prednisolone for the UK market.
Renata Chairman SH Kabir presided over the meeting, said a press release.
CEO and Managing Director Kaiser Kabir, directors Dr Sarwar Ali, Sajida Humayun Kabir, A Hasanat Khan, Manzoor Hasan, Company Secretary Md Shafiul Alam, senior executives of the company and a large number of shareholders attended the AGM.
In the year 2009, Renata's combined turnover and net profit grew by 26.2 per cent and 39.3 per cent respectively last year. The earning per share (EPS) stood at Tk 417.38 compared to Tk 299.55 in the year 2008. The retained earnings of the company on December 31st 2009 amounted to a healthy Tk 1.7 billion. Renata also contributed Tk 862 million to the national exchequer in the form of corporate taxes, value added tax and import duties.
The Chairman informed the meeting that in last six years, Renata increased the number of manufacturing facilities from one to five-fold. The entire investments were financed through internally generated funds, and the company remains free of long-term debt.
Renata's pharmaceutical business registered a growth of 27.5 per cent and improved its market rank from 6th to 5th. In the animal health business, Renata retained its number 1 position for the 13th consecutive year with a sales growth of 28 per cent.
In contract manufacturing, Renata produced Sprinkles for SMC and UNICEF, and Prednisolone for the UK market.